Alkermes (ALKS) stock Forecast for 2021 – 2025

Alkermes (ALKS) stock Forecast for 2022 – 2026

Last update: March 23, 2023 (12:33)

Sector: Healthcare

The share price of Alkermes plc (ALKS) now

What analysts predict: $33.2
52-week High/Low: $32.79 / $21.75

50/200 Day Moving Average: $27.37 / $25.98

This figure corresponds to the Average Price over the previous 50/200 days. For Alkermes stocks, the 50-day moving average is the resistance level today.

For Alkermes stocks, the 200-day moving average is the resistance level today.

Are you interested in Alkermes plc stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Alkermes stock price in 2023, 2024, 2025, 2026, 2027. How much will one Alkermes share be worth in 2023 - 2027?

When should I take profit in Alkermes stock? When should I record a loss on Alkermes stock? What are analysts' forecasts for Alkermes stock? What is the future of Alkermes stock? We forecast Alkermes stock performance using neural networks based on historical data on Alkermes stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Alkermes stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2023, 2024, 2025, 2026 and 2027) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Alkermes shares. This happens once a day.




Historical and forecast chart of Alkermes stock

The chart below shows the historical price of Alkermes stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Alkermes stock price can be found in the table below.

Long-term forecasts by years.

Alkermes daily forecast for a month

Date Target Pes. Opt. Vol., %
Mar 25 26.17 25.74 26.78 4.07
Mar 26 25.80 25.37 26.11 2.90
Mar 27 25.05 24.48 25.69 4.95
Mar 28 25.34 24.70 25.95 5.06
Mar 29 25.18 24.66 25.35 2.78
Mar 30 24.81 24.61 25.10 2.00
Mar 31 24.41 24.15 24.81 2.75
Apr 01 24.49 24.21 25.11 3.72
Apr 02 24.00 23.59 24.33 3.13
Apr 03 23.74 23.36 24.33 4.13
Apr 04 22.98 22.39 23.53 5.09
Apr 05 23.59 23.16 23.75 2.58
Apr 06 24.02 23.62 24.42 3.42
Apr 07 24.51 24.08 25.03 3.97
Apr 08 24.16 23.55 24.63 4.56
Apr 09 24.60 24.11 25.07 3.98
Apr 10 25.34 24.90 25.84 3.78
Apr 11 25.64 24.99 26.00 4.04
Apr 12 24.91 24.47 25.48 4.14
Apr 13 24.44 24.20 24.94 3.07
Apr 14 24.29 23.94 24.51 2.40
Apr 15 23.59 23.32 23.87 2.36
Apr 16 23.56 23.24 23.81 2.47
Apr 17 23.69 23.34 23.95 2.63
Apr 18 24.21 24.05 24.38 1.39
Apr 19 24.35 24.11 24.75 2.68
Apr 20 24.00 23.54 24.32 3.29
Apr 21 23.54 23.36 23.76 1.74
Apr 22 22.86 22.65 23.07 1.87
Apr 23 22.43 21.89 22.97 4.95

Alkermes Daily Price Targets


Alkermes Stock Forecast 03-25-2023.

Forecast target price for 03-25-2023: $26.17.
Positive dynamics for Alkermes shares will prevail with possible volatility of 3.909%.
Pessimistic target level: 25.74
Optimistic target level: 26.78

Alkermes Stock Forecast 03-26-2023.

Forecast target price for 03-26-2023: $25.80.
Negative dynamics for Alkermes shares will prevail with possible volatility of 2.814%.
Pessimistic target level: 25.37
Optimistic target level: 26.11

Alkermes Stock Forecast 03-27-2023.

Forecast target price for 03-27-2023: $25.05.
Negative dynamics for Alkermes shares will prevail with possible volatility of 4.713%.
Pessimistic target level: 24.48
Optimistic target level: 25.69

Alkermes Stock Forecast 03-28-2023.

Forecast target price for 03-28-2023: $25.34.
Positive dynamics for Alkermes shares will prevail with possible volatility of 4.812%.
Pessimistic target level: 24.70
Optimistic target level: 25.95

Alkermes Stock Forecast 03-29-2023.

Forecast target price for 03-29-2023: $25.18.
Negative dynamics for Alkermes shares will prevail with possible volatility of 2.702%.
Pessimistic target level: 24.66
Optimistic target level: 25.35

Alkermes Stock Forecast 03-30-2023.

Forecast target price for 03-30-2023: $24.81.
Negative dynamics for Alkermes shares will prevail with possible volatility of 1.961%.
Pessimistic target level: 24.61
Optimistic target level: 25.10

ALKS (ALKS) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Apr. 24.57 22.40 27.87 19.63
May. 23.86 21.30 24.75 13.93
Jun. 23.94 21.46 25.16 14.72
Jul. 23.49 20.78 25.65 19.00
Aug. 20.50 18.09 23.22 22.06
Sep. 19.80 17.48 21.82 19.90
Oct. 20.34 18.26 21.31 14.28
Nov. 21.93 19.84 23.87 16.87
Dec. 23.31 21.01 25.61 17.95

Alkermes forecast for this year


Alkermes Stock Prediction for Apr 2023

An downtrend is forecast for this month with an optimal target price of $24.5697. Pessimistic: $22.40. Optimistic: $27.87


Alkermes Stock Prediction for May 2023

An downtrend is forecast for this month with an optimal target price of $23.8597. Pessimistic: $21.30. Optimistic: $24.75


Alkermes Stock Prediction for Jun 2023

An uptrend is forecast for this month with an optimal target price of $23.9408. Pessimistic: $21.46. Optimistic: $25.16


Alkermes Stock Prediction for Jul 2023

An downtrend is forecast for this month with an optimal target price of $23.4931. Pessimistic: $20.78. Optimistic: $25.65


Alkermes Stock Prediction for Aug 2023

An downtrend is forecast for this month with an optimal target price of $20.4977. Pessimistic: $18.09. Optimistic: $23.22


Alkermes Stock Prediction for Sep 2023

An downtrend is forecast for this month with an optimal target price of $19.8008. Pessimistic: $17.48. Optimistic: $21.82


Alkermes Stock Prediction for Oct 2023

An uptrend is forecast for this month with an optimal target price of $20.3394. Pessimistic: $18.26. Optimistic: $21.31


Alkermes Stock Prediction for Nov 2023

An uptrend is forecast for this month with an optimal target price of $21.9299. Pessimistic: $19.84. Optimistic: $23.87


Alkermes Stock Prediction for Dec 2023

An uptrend is forecast for this month with an optimal target price of $23.3093. Pessimistic: $21.01. Optimistic: $25.61



Alkermes (ALKS) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 26.44 23.88 29.95 20.26
Feb 27.02 24.54 28.59 14.14
Mar 26.52 23.59 29.22 19.28
Apr 27.78 24.48 31.23 21.63
May 32.27 29.42 33.69 12.70
Jun 37.70 36.03 41.09 12.32
Jul 43.66 39.95 47.96 16.71
Aug 40.76 37.85 43.88 13.74
Sep 46.52 44.22 49.20 10.12
Oct 53.87 50.02 56.07 10.78
Nov 46.91 43.48 50.18 13.35
Dec 43.64 37.93 48.54 21.86

Alkermes (ALKS) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 42.38 37.98 47.49 20.02
Feb 43.17 37.45 46.69 19.80
Mar 43.02 39.08 44.78 12.74
Apr 40.90 36.73 46.05 20.23
May 42.50 39.03 47.78 18.30
Jun 42.14 39.20 46.80 16.23
Jul 36.91 33.40 38.54 13.35
Aug 34.34 29.67 37.78 21.48
Sep 28.68 25.31 29.94 15.47
Oct 28.92 27.89 31.08 10.28
Nov 30.25 28.35 31.74 10.69
Dec 31.12 27.26 33.13 17.72

Alkermes (ALKS) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 28.48 26.64 31.38 15.12
Feb 26.73 23.69 29.19 18.84
Mar 25.73 22.85 28.53 19.93
Apr 24.95 22.87 26.60 14.03
May 28.08 26.37 29.42 10.39
Jun 29.37 27.43 31.82 13.81
Jul 28.48 25.09 31.77 21.03
Aug 29.06 26.09 31.67 17.62
Sep 30.88 27.68 33.67 17.78
Oct 30.88 27.73 32.20 13.86
Nov 34.98 31.71 38.96 18.62
Dec 39.97 35.49 44.32 19.93

Alkermes (ALKS) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 45.89 42.22 47.45 11.02
Feb 47.60 42.99 51.73 16.90
Mar 43.88 39.18 46.34 15.45
Apr 42.76 39.27 45.52 13.73
May 45.60 42.57 47.15 9.70
Jun 42.57 37.65 44.53 15.44
Jul 41.27 37.62 46.39 18.90
Aug 39.02 34.58 41.41 16.50
Sep 41.88 38.10 46.43 17.94
Oct 34.97 33.25 38.06 12.65
Nov 33.25 30.48 35.57 14.30
Dec 35.96 33.27 39.93 16.69

Alkermes information and performance

Alkermes plc is an Irish biopharmaceutical company that researches, develops and markets pharmaceutical products used in a variety of therapeutic areas around the world. The company’s products include drugs for the treatment of schizophrenia, schizoaffective, depressive and bipolar disorder, alcohol and opioid addiction, aids to improve walking in adults with multiple sclerosis, and a drug for the treatment of type 2 diabetes. The company serves pharmaceutical wholesalers, specialized pharmacies and distributors.

Alkermes Address

CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, IE

Market Capitalization: 4 390 116 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: -64 403 000 $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: -1057.29

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -0.94

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: -0.061
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 588.24

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 3.566

Enterprise Value (EV) /Revenue

EV To EBITDA: -72.85

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 164389000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.